MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN) today announced that it will present at the Baird 2006 Growth Stock Conference on Wednesday, May 10, 2006 at 1:20 p.m. Central Time. Marty Duvall, Senior Vice President, Commercial Operations of MGI PHARMA will give the presentation, which will be webcast live over the Internet. The conference will be held at the Four Seasons Hotel in Chicago, IL.
What: MGI PHARMA's presentation at the Baird 2006 Growth Stock Conference
When: Wednesday, May 10, 2006 at 1:20 p.m. Central Time
How: Live over the Internet - simply log on to www.mgipharma.com. In addition to the live webcast, the presentation will be archived on the Company's Web site for one week.
About MGI PHARMA
MGI PHARMA, INC. is an oncology- and acute care-focused biopharmaceutical company that acquires, researches, develops and commercializes proprietary products that address the unmet needs of patients. MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) injection and Gliadel(R) Wafer (polifeprosan 20 with carmustine implant) in the United States. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets. For more information about MGI PHARMA, please visit www.mgipharma.com.
No comments:
Post a Comment